Position of an international panel of lung cancer experts on the decision for expansion of approval for pembrolizumab in advanced non-small-cell lung cancer with a PD-L1 expression level of ≥1% by the USA Food and Drug Administration
- PMID: 31504132
- DOI: 10.1093/annonc/mdz295
Position of an international panel of lung cancer experts on the decision for expansion of approval for pembrolizumab in advanced non-small-cell lung cancer with a PD-L1 expression level of ≥1% by the USA Food and Drug Administration
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials